Total for the last 12 months
number of access : ?
number of downloads : ?
ID 118934
Author
Horii, Yuma Kyushu University
Matsuda, Shoichi Kyushu University
Toyota, Chikashi Kyushu University
Morinaga, Takumi Kyushu University
Nakaya, Takeo Jichi Medical University
Tsuchiya, Soken Kumamoto University
Ohmuraya, Masaki Hyogo College of Medicine
Hironaka, Takanori Kyushu University
Yoshiki, Ryo Kyushu University
Kasai, Kotaro Kyushu University
Yamauchi, Yuto Kyushu University
Takizawa, Noburo Kyushu University
Nagasaka, Akiomi Kyushu University
Tanaka, Akira Jichi Medical University
Nakaya, Michio Kyushu University|Japan Agency for Medical Research and Development
Content Type
Journal Article
Description
Myofibroblasts cause tissue fibrosis by producing extracellular matrix proteins, such as collagens. Humoral factors like TGF-β, and matrix stiffness are important for collagen production by myofibroblasts. However, the molecular mechanisms regulating their ability to produce collagen remain poorly characterised. Here, we show that vestigial-like family member 3 (VGLL3) is specifically expressed in myofibroblasts from mouse and human fibrotic hearts and promotes collagen production. Further, substrate stiffness triggers VGLL3 translocation into the nucleus through the integrin β1-Rho-actin pathway. In the nucleus, VGLL3 undergoes liquid-liquid phase separation via its low-complexity domain and is incorporated into non-paraspeckle NONO condensates containing EWS RNA-binding protein 1 (EWSR1). VGLL3 binds EWSR1 and suppresses miR-29b, which targets collagen mRNA. Consistently, cardiac fibrosis after myocardial infarction is significantly attenuated in Vgll3-deficient mice, with increased miR-29b expression. Overall, our results reveal an unrecognised VGLL3-mediated pathway that controls myofibroblasts’ collagen production, representing a novel therapeutic target for tissue fibrosis.
Journal Title
Nature Communications
ISSN
20411723
NCID
AA12645905
Publisher
Springer Nature
Volume
14
Start Page
550
Published Date
2023-02-08
Rights
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
EDB ID
DOI (Published Version)
URL ( Publisher's Version )
FullText File
language
eng
TextVersion
Publisher
departments
Institute of Advanced Medical Sciences